Everolimus
Also known as Afinitor (us), Evertor (india)
An immunosuppressant / targeted therapy used in transplant and some cancers.
United States
$790
per month
India
$461
per month
You save
−42%save $329/mo · 42% cheaper
42K US scripts/yr$13.8M potential annual savings$33.2M US spend/yr
Drag to rotate · 3D structureC53H83NO14
SMILES: C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC
Compare the price
US price$790per month
India price$461per month
You save$32942% less
Based on 30 tablets per month. US $26.32 vs India $15.35 per tablet.
Total over 1 periodSave $329$790 → $461
The bigger picture
Everolimus is filled about 42K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$33.2M
If sourced from India
$19.3M
Potential annual savings
$13.8M
−42%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.